113 related articles for article (PubMed ID: 11522478)
21. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
[TBL] [Abstract][Full Text] [Related]
22. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review.
Singla AK; Chawla M; Singh A
Drug Dev Ind Pharm; 2000 Sep; 26(9):913-24. PubMed ID: 10914315
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, development and in vitro evaluation of drug delivery systems with protective effect against degradation by pepsin.
Bernkop-Schnürch A; Kirchmayer R; Kratzel M
J Drug Target; 1999; 7(1):55-63. PubMed ID: 10614815
[TBL] [Abstract][Full Text] [Related]
24. Recent development of poly(ethylene glycol)-cholesterol conjugates as drug delivery systems.
He ZY; Chu BY; Wei XW; Li J; Edwards CK; Song XR; He G; Xie YM; Wei YQ; Qian ZY
Int J Pharm; 2014 Jul; 469(1):168-78. PubMed ID: 24768727
[TBL] [Abstract][Full Text] [Related]
25. An oral oligonucleotide delivery system based on a thiolated polymer: Development and in vitro evaluation.
Martien R; Hoyer H; Perera G; Schnürch AB
Eur J Pharm Biopharm; 2011 Aug; 78(3):355-60. PubMed ID: 21295141
[TBL] [Abstract][Full Text] [Related]
26. Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
Werle M; Takeuchi H
Int J Pharm; 2009 Mar; 370(1-2):26-32. PubMed ID: 19073243
[TBL] [Abstract][Full Text] [Related]
27. Effects of polyacrylic polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin.
Bai JP; Chang LL; Guo JH
J Pharm Pharmacol; 1996 Jan; 48(1):17-21. PubMed ID: 8722488
[TBL] [Abstract][Full Text] [Related]
28. Oxidation-Responsive Polymer-Drug Conjugates with a Phenylboronic Ester Linker.
Qiu FY; Zhang M; Ji R; Du FS; Li ZC
Macromol Rapid Commun; 2015 Nov; 36(22):2012-8. PubMed ID: 26297612
[TBL] [Abstract][Full Text] [Related]
29. Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin.
Luessen HL; Verhoef JC; Borchard G; Lehr CM; de Boer AG; Junginger HE
Pharm Res; 1995 Sep; 12(9):1293-8. PubMed ID: 8570524
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and characterisation of mucoadhesive thiolated polymers.
Bernkop-Schnürch A; Steininger S
Int J Pharm; 2000 Jan; 194(2):239-47. PubMed ID: 10692648
[TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of the permeation enhancing effect of polycarbophil-cysteine conjugates on the cornea of rabbits.
Hornof MD; Bernkop-Schnürch A
J Pharm Sci; 2002 Dec; 91(12):2588-92. PubMed ID: 12434402
[TBL] [Abstract][Full Text] [Related]
32. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates.
Bernkop-Schnürch A; Krajicek ME
J Control Release; 1998 Jan; 50(1-3):215-23. PubMed ID: 9685888
[TBL] [Abstract][Full Text] [Related]
33. Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages.
Lele BS; Hoffman AS
J Control Release; 2000 Nov; 69(2):237-48. PubMed ID: 11064131
[TBL] [Abstract][Full Text] [Related]
34. The primary elastase inhibitor (elastasin) and trypsin inhibitor (contrapsin) in the goat are serpins related to human alpha 1-anti-chymotrypsin.
Potempa J; Enghild JJ; Travis J
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):191-7. PubMed ID: 7864809
[TBL] [Abstract][Full Text] [Related]
35. Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration.
Werle M; Kafedjiiski K; Kolmar H; Bernkop-Schnürch A
Int J Pharm; 2007 Mar; 332(1-2):72-9. PubMed ID: 17070661
[TBL] [Abstract][Full Text] [Related]
36. Intestinal peptide and protein delivery: novel bioadhesive drug-carrier matrix shielding from enzymatic attack.
Bernkop-Schnürch A; Pasta M
J Pharm Sci; 1998 Apr; 87(4):430-4. PubMed ID: 9548894
[TBL] [Abstract][Full Text] [Related]
37. An examination of the rheological and mucoadhesive properties of poly(acrylic acid) organogels designed as platforms for local drug delivery to the oral cavity.
Jones DS; Muldoon BC; Woolfson AD; Sanderson FD
J Pharm Sci; 2007 Oct; 96(10):2632-46. PubMed ID: 17702045
[TBL] [Abstract][Full Text] [Related]
38. Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution.
Rodrigues PC; Beyer U; Schumacher P; Roth T; Fiebig HH; Unger C; Messori L; Orioli P; Paper DH; Mülhaupt R; Kratz F
Bioorg Med Chem; 1999 Nov; 7(11):2517-24. PubMed ID: 10632061
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine).
Schiavon O; Caliceti P; Ferruti P; Veronese FM
Farmaco; 2000 Apr; 55(4):264-9. PubMed ID: 10966157
[TBL] [Abstract][Full Text] [Related]
40. Thiolated polycarbophil as an adjuvant for permeation enhancement in nasal delivery of antisense oligonucleotides.
Vetter A; Martien R; Bernkop-Schnürch A
J Pharm Sci; 2010 Mar; 99(3):1427-39. PubMed ID: 19708062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
